Paula C. Luna

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Biologic therapies in pediatric psoriasis: A single-center experience.

Biologic therapies in pediatric psoriasis: A single-center experience.

Journal: Archivos argentinos de pediatria

Published: June 30, 2026

Bridging the gap between the clinical need and drug approval in paediatric auto immune blistering diseases.

Bridging the gap between the clinical need and drug approval in paediatric auto immune blistering diseases.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 21, 2026

Pembrolizumab-induced psoriasis and radiation recall: a shared immune pathway unveiled.

Pembrolizumab-induced psoriasis and radiation recall: a shared immune pathway unveiled.

Journal: Anais brasileiros de dermatologia

Published: March 05, 2026

Efficacy of Upadacitinib in Patients with Atopic Dermatitis of the Head and Neck Region.

Efficacy of Upadacitinib in Patients with Atopic Dermatitis of the Head and Neck Region.

Journal: Dermatology and therapy

Published: February 23, 2026

Effectiveness and Safety of IL-17A Inhibitors in Pediatric Psoriasis: A Real-World, Multicenter, International Study.

Effectiveness and Safety of IL-17A Inhibitors in Pediatric Psoriasis: A Real-World, Multicenter, International Study.

Journal: Paediatric drugs

Published: February 11, 2026

Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials.

Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials.

Journal: Lancet (London, England)

Published: August 08, 2025

International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomes.

International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomes.

Journal: Journal of the American Academy of Dermatology

Published: June 30, 2025

Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months.

Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months.

Journal: Dermatology and therapy

Published: May 06, 2025

Real-World Experience of Dupilumab in Children and Adolescents With Atopic Dermatitis in Argentina.

Real-World Experience of Dupilumab in Children and Adolescents With Atopic Dermatitis in Argentina.

Journal: Pediatric dermatology

Published: March 12, 2025

ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis.

ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis.

Journal: Immunotherapy

Published: February 27, 2025

Unraveling Psoriasis Flare-up and Dengue Infection.

Unraveling Psoriasis Flare-up and Dengue Infection.

Journal: Journal of psoriasis and psoriatic arthritis

Published: January 24, 2025

Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months.

Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months.

Journal: Dermatology and therapy

Published: December 10, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026